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Abstract Stem cells therapy is a new promising approach for
diabetes mellitus (DM) treatment, but the insulin secretion
rate in differentiated cells is low when compared with pan-
creas beta cells embedded in Langerhans islets. In this study,
we evaluated different protocols of insulin secretion to
achieve the most appropriate protocol for in vitro insulin
secretion. We differentiated human umbilical cord matrix-
derived mesenchymal cells (hUCMs) into insulin-
producing cell (IPC) by the aim of three previously reported
protocols and a modified protocol. The insulin content was
analyzed through gene expression and immunocytochemis-
try (IHC). Dithizone (DTZ) staining was done for identifi-
cation of islet-like structures. Insulin and C peptide secretion
was measured by chemiluminesence immunoassay (CLIA)
and enzyme immunoassay (EIA) as well. Reverse
transcription-PCR (RT-PCR) showed efficient expression of
insulin genes in all the study groups. IHC analysis showed
higher expression of insulin and proinsulin proteins in the
modified protocol. DTZ staining exhibited variable islet-like
clusters in the different protocols except control. This find-
ing was confirmed by the higher response to glucose chal-
lenge test in this group. A modified protocol using an inter-
mediate step that makes the cells vulnerable to nestin pro-
duction in combination with inducing agent results in the
higher differentiation of stem cells into insulin-producing
cells and more insulin secretion in vitro.
Keywords Human umbilical cordmatrix-derived
?mesenchymal cells (hUCMs) . Insulin-producing cell (IPC) .
Nestin . Differentiation protocol
Introduction
The permanent destruction of insulin-producing cells results
in type I diabetes mellitus (DM), a degenerative disease with
worldwide distribution and increasing attacks (Himsworth
2011). Stem cells therapy is a new promising approach for
DM treatment (Hussain and Theise 2004). Among the stem
cells, mesenchymal stem cells (MSC) are highly recom-
mended for cell-based therapies due to the safety and easy
access compared with embryonic stem cells (Jahr and
Bretzel 2003). MSCs have been defined by their subsequent
expansion under appropriate culture conditions and their dif-
ferentiation potential in vitro and in vivo (Javazon et al.
2004). MSCs are usually isolated from bone marrow, umbil-
ical cord matrix and blood, periosteum, adipose tissue,
synovium, skeletal muscle, and some other tissues (Barry
and Murphy 2004). Phenotypically, MSC have been report-
ed to be positive for CD73, CD44, CD90, and CD105 and
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negative for hematopoietic lineage markers such as CD45,
CD34, and HLA-DR (Wang et al. 2004; Wagner et al.
2005). Under appropriate induction conditions, these cells
can differentiate into a variety of cell types, including fat,
bone, and cartilage cells (Lee et al. 2004).
Several investigations have shown that MSCs can suc-
cessfully differentiate into insulin-producing cells (IPC), in-
cluding pancreatic stem cell (Gao et al. 2003), human adi-
pose tissue-derived mesenchymal stem cells (MSCs)
(Timper et al. 2006), bone marrow-derived MSCs (Chen
et al. 2004; Wu et al. 2009), human umbilical cord blood
(Sun et al. 2007a, b; Van Phuc et al. 2011; Nguyen et al.
2014), human umbilical cord matrix (Chao et al. 2008;
Wang et al. 2011), amniotic fluid (Carnevale et al. 2013),
human periosteum (Kim et al. 2012), and dental pulp
(Carnevale et al. 2013). However, the rate of insulin secre-
tion is low when compared with the rate of insulin secretion
of pancreas beta cells embedded in Langerhans islets (Serup
et al. 2001; Chao et al. 2008; Wang et al. 2011). The fre-
quently used extrinsic factors for the induction of stem cells
towards IPCs include nicotinamide (Otonkoski et al. 1993;
Gabr et al. 2008; Gao et al. 2008), exendin-4 (Gabr et al.
2008; Li et al. 2010), gastrin (Wang et al. 1993), HGF
(Otonkoski et al. 1996), bFGF (Hardikar et al. 2003), activin
A (Demeterco et al. 2000), betacellulin (Demeterco et al.
2000), and low concentration of glucose (Bonner-Weir et al.
1989). In addition to the different inducing substances being
used so far, different cocktails have been used in the various
studies. Some protocols have shown an increase in the insu-
lin content (Sun et al. 2007a, b), while others amplified IPCs
insulin secretion and their response to glucose challenge test
(Chao et al. 2008; Gao et al. 2008).
Although different methods have been used for differen-
tiation of stem cells into IPCs, but inadequate differentia-
tion, insufficient insulin secretion, and low response to glu-
cose challenge test are still challenging (Hussain and
Theise 2004). Since expression of nestin, an intermediate
filament, has been reported as a necessary intermediate
stage for the IPC and neuronal differentiation (Hunziker
and Stein 2000), some researchers have utilized neuronal-
conditioned medium (NCM) at different stages of in vitro
IPC differentiation to attain higher insulin production in the
differentiated cells (Chao et al. 2008). It seems that using
an intermediate step of nestin production for the induction
of MSCs followed by the inducing agents may result in
higher insulin secretion in vitro.
To examine this hypothesis, we have employed a newmod-
ified differentiation protocol and compared it with the three
commonly reported protocols. Reverse transcription-PCR
(RT-PCR), ICC, dithizone staining, chemiluminescence im-
munoassay (CLIA), and enzyme immunoassay (EIA) were
used to evaluate the efficacy of different strategies for the
in vitro insulin secretion.
Materials and methods
All the materials were purchased from Sigma Company (Sig-
ma, Basel, Switzerland) unless those otherwise stated. Ethical
approval has been issued by the Institutional Ethical Review
Board (approval number 69-1780) at Kerman University of
Medical Sciences, Kerman, Iran.
hUCMCs isolation The protocol for the isolation and culture
of hUCMs has been described elsewhere (Salehinejad et al.
2012). Briefly, human Wharton Jelly (WJ), was cut into small
pieces and cultured in DMEMF12 supplemented with 10%
FBS (Gibco), 100 IU/ml penicillin, streptomycin, and
2 μg/ml amphotericin B until the hUCM cells were propagat-
ed from the boundary of the explants. hUCM cells at 80%
confluence were harvested by trypsin and ethylenediaminetet-
raacetic acid (EDTA) digestion. The viable cells were either
used for experiments or cryopreserved with conventional
freezing protocols (Kaviani et al. 2014).
Flow cytometry To confirm the mesenchymal and stemness
properties of the isolated cells, the cell surface markers were
determined using flow cytometry method accordingly; 1×105
hUCMs after the first passage were harvested, and the follow-
ing markers including CD34, CD45, CD73, and CD90 were
analyzed. The cells were fixed with 4% paraformaldehyde for
15 min, washed with phosphate-buffered saline (PBS), and
incubated with goat serum in PBS to block non-specific bind-
ing protein. The cells were then exposed to 3–5 μl PE-
conjugated anti-CD34, CD45, CD73, and CD90 for 1 h at
4°C. At least 10,000 events were recorded with flow
cytometer machine (BDBiosciences). The data were analyzed
by WinMDI software.
Osteogenic and adipogenic differentiation Adipogenic and
osteogenic differentiation was induced as previously de-
scribed (Salehinejad et al. 2012). About 5×104 hUCM cells
were initially cultured for 24 h in 3-cm culture plates, and the
osteogenic medium consisted of DMEMF12 supplemented
with 10% FBS, 10 mM β-glycerophosphate, 10 nM dexa-
methasone, and 82 μg/ml ascorbic acid was added for 21 d.
Differentiated cells were stained with Alizarin red and ob-
served with a light microscope (Olympus, Japan).
For adipogenic induction, after 24 h initial culture, the cells
were cultured for 14 d in adipogenic medium (Invitrogen,
Carisbad, CA, A1007001). The differentiated cells were
stained by Oil red O and observed with a light microscope.
The same protocols were used for negative control, except that
the adipogenic induction was omitted.
Differentiation of hUCMs to IPCs In the present study, four
different protocols were employed for IPCs differentiation.
The number of 4×105 hUCMs was cultured in 25 cm culture
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flask, and after 80% confluence, differentiation protocols were
carried out according to Table 1. The medium was refreshed
every 3 d except in the stage 2 from protocol I and also the
modified protocol that the medium was changed every other
day.
Preparation of the neuronal-conditioned medium Seven-
day-old rats were killed, and their brains were removed. After
thoroughly rinse in PBS, the brains were immersed in
DMEM-F12 with 10% FBS, cut into small pieces, grounded
and abraded, and passed through a 50-μm steel mesh to obtain
single cells. The samples were then immersed in DMEM-F12
supplemented with 10% FBS and incubated at 37°C with 5%
CO2 in the air for 24 h. The supernatant containing neural cells
and excluding oligodendroglia (adherent cells) was trans-
ferred to a new flask and incubated with 10% FBS-DMEM
at 37°C and 5% CO2 in the air for 4 d. NCM was prepared
after two times centrifugation at 3000 rpm for 5 min.
Stem cell-conditioned medium preparation hUCMs were
cultured in DMEMF12 supplemented with 2% FBS, 10 mM
nicotinamide, and 1 mM glutamine for 3 d. The supernatant
was then removed and used as stem cell-conditioned medium
(SCM) (Chao et al. 2008).
NCM exposure time determination and anti-nestin
immunocytochemistry For determining the appropriate time
of NCM exposure, about 10×104 hUCM cells were cultured
for 24 h in 6 cm culture plates and the NCM was mixed with
an equal volume of complete culture medium. The medium
was changed every other day. The culture dishes were ana-
lyzed for nestin expression by immunocytochemistry (ICC) at
days 3, 5, and 7. For the detection of nestin expression, the
cells in protocols I and IV, after stage 2 were fixed with 4%
paraformaldehyde for 30 min and subsequently washed with
PBS. The cells were stained using mouse anti-nestin antibody
(Abcam) followed by a Dako Envision+Dual system-HRP kit
(Dako-Cytomation Inc., Carpenteria, CA) as recommended
by the manufacturer. The cell nuclei were counterstained with
hematoxylin for 2 min and observed under a light microscope
(Nikon TS100).
Reverse transcription-PCR At the end of the differentiation
time, the cells were collected to examine the expression of
insulin gene. Total RNA was extracted by Total RNA Purifi-
cation Kit (Jena Bioscience). The RNA samples were treated
with DNase Ι (Fermentas) to eliminate any DNA contamina-
tion; 100 ng total RNAwas then used for complementary DNA
(cDNA) synthesis with Accupower Cycle Script RT Premix kit
(Bioneer). Primers in Table 2 were used for RT-PCR reaction.
The PCR reactions were accomplished in 20 μl reaction mix-
tures containing 2 μl of cDNA, 2 μl forward and reverse
primers, 10 μl master mix (Amplicon), and 6 μl Dnase/
RNase-free water. Thirty-five cycles were carried out using
the following program and a thermal cycler machine (Bio-
Rad c1000 USA): 4 min denature step at 95°C, 35 cycles at
94°C for 30 s, 30 s of annealing step at 58–60°C, and elonga-
tion step at 72°C for 45 s with a final extension at 72°C for
Table 1. Details of various protocols
Protocols Stages Compositions Duration (d) References
I Stage 1 DMEMF12+10% FBS 3–6 Chao et al. (2008)
Stage 2 NCM 7
Stage 3 DMEMF12 (25 mM glucose)+nicotinamide (10 mM)+2% FBS 7
Stage 4 DMEMF12 (25 mM glucose)+nicotinamide (10 mM)+2% FBS+ITS+SCM 14
II Serum-free DMEMF12+glucose (17.5 mM)+nicotinamide (10 mM)+exendin-4
(10 nM)+hepatocyte growth factor (100 pM)+pentagastrin
(10 nM)+B27 serum-free supplement (Gibco)
14 Timper et al. (2006)
III Stage 1 H-DMEM medium, 5% FBS+nicotinamide (10 mM)+exendin-4 (10 nM) 14 Wu et al. (2009)
Stage 2 Addition of nicotinamide (10 mM) 7
Stage 3 Addition of exendin-4 (10 nM) 7
IV Stage 1 DMEMF12+10% FBS 3 New modified protocol
Stage 2 NCM 5
Stage 3 Serum-free DMEM/F12+glucose (17.5 m M)+nicotinamide
(10 mM)+exendin-4 (10 nM)+pentagastrin (10 nM)+hepatocyte growth
factor (100 pM)+B27 serum-free supplement (Gibco)
9
Table 2. Primer sequences for RT-PCR
Gene Size Strand Sequence
GAPDH 86 F TGCACCACCAACTGCTTAGCT
R GGCATGGACTGTGGTCATGAG




5 min. PCR products were transferred to 2% agarose gel and
visualized with a gel documentation system (Bio-Rad USA).
Immunocytochemistry analysis of insulin and proinsulin
The differentiated cells were fixed in 4% paraformaldehyde
for 30 min, washed with PBS, and incubated in PBS contain-
ing 0.5% Triton X-100 and 10% goat serum for 45 min at
37°C to block non-specific banding protein sites. The primary
guinea pig anti-insulin antibody (Ab7842, 1:100) and anti-
proinsulin antibody (Ab7761, 1:200) were then added over-
night at 4°C, followed by incubation with Alexa Fluor 488
Goat Anti-guinea Pig IgG (Ab150185) and Alexa Flour Goat
Anti-mouse IgG (Invitrogen) as secondary antibodies for
45 min at room temperature. The cells nuclei were visualized
by 5 μg/ml Hoechst 33258. The stained cells were observed
under a fluorescence-inverted microscope equipped with a
digital camera (DP71, Olympus, Japan).
Dithizone staining About 5×104 hUCM cells were cultured
in 3 cm culture plates and were exposed to various protocols.
After differentiation of the hUCMs into IPCs, dithizone
(DTZ) stainingwas performed to confirm IPCs differentiation.
A stock solution was prepared by dissolving 10 mg dithizone
(D5130) in 1 ml dimethyl sulfoxide (DMSO); 10 μl stock
solution was then mixed with 1 ml PBS, and the culture dishes
were incubated in DTZ solution for 15 min at 37°C, washed
subsequently three times with PBS, mounted with glycerol,
and observed with an inverted microscope (Olympus, Japan)
equippedwith a digital camera. Undifferentiated hUCMswere
used as negative control.
Biochemical assessment of insulin, C peptide secretion,
and glucose sensitivity At the end of differentiation period,
the cells were cultured overnight in low glucose DMEM me-
dium supplemented with 2% FBS. The cells were then
Fig. 1 Projection of hUCMs cells
from human Wharton Jelly
boundary (A). Colony formation
in hUCM cells (B). Alizarin red
staining, displayed Ca2+
aggregation in the extracellular
matrix of induced cells (C) and
lake of this in non-induced hUCM
cells (D). Oil red staining exhib-
ited lipid droplets in the cyto-
plasm of the induced cells (E) and
lake of this in non-induced
hUCMs cells (F). Magnifications
A ×100 and B, C, D, E, and F
×200).
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Fig. 2 Flow cytometry analysis of hUCM cells. Red histograms display the isotype control-stained cells, and the black histograms show the antibody-
stained cells.
Fig. 3 Immunocytochemical
analysis on nestin protein in
protocol I (A), protocol IV (B),




exposed to high and low glucose medium for 1 h, respectively,
to determine the insulin secretion. The supernatant was col-
lected and kept frozen at −20°C for the assessment of insulin
and C peptide secretion by CLIA and EIA, respectively.
Statistical analysis Data from different groups were analyzed
by one-way ANOVA and tukey post- hoc test. A difference of
p≤0.05 was considered statistically significant. The data were
presented as mean±SE.
Results
hUCM cells isolation The isolated cells were observed 7–10 d
after the initiation of explant culture at the boundary of the tissue
fragments (Fig. 1A). The majority of cells were elongated with
several cytoplasmic processes, while few of them exhibited
round shape with small cell processes. By extending the culture
period, cell colonies became visible in culture (Fig. 1B). Mitotic
index was high in these cells (data not shown). At confluence of
>80%, the cells were detached from the substratumwith trypsin/
EDTA and expanded for further experiments.
Flow cytometery and surface marker assessment The iso-
lated cells at the first passage were analyzed for mesenchymal
cell markers as well as hematopoietic markers. The majority
of adherent cells were negative for CD34 and CD45, indicat-
ing that these cells were not of hematopoietic origin, while
they were positive for CD73 and CD90, which is specific
for cells of the mesenchymal origin (Fig. 2).
Osteogenic and adipogenic differentiation In the osteogen-
ic induction medium, hUCM differentiated into osteocytes
with numerous cell expansions. Alizarin red staining demon-
strated calcium phosphate deposits in extracellular matrix
(Fig. 1C). The presence of adipocytes with lipid droplets
Fig. 4 Morphological changes in
different groups of hUCM cells.
Undifferentiated hUCM cells (A),
differentiated cells in protocols I
(B), II (C), III (D), and IVafter 7 d
(E) and 14 d (F). The arrows
show round shape of the cells in
(D) and (E) and cluster formation
in (B), (C), and (F). Magnification
×200.
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stained with Oil red O demonstrated the adipogenic differen-
tiation of hUCMs (Fig. 1E). No spontaneous differentiation
was observed in control cultures (Fig. 1D, F).
NCM appropriate exposure time determination
Immunocytochemical analysis was carried out for the detec-
tion of nestin protein, after exposure of hUCM to NCM for 3,
5, and 7 d. Proportion of nestin positive cells was 30±3.7, 61±
3.8, and 89±2.8 for 3, 5, and 7 d exposure times, respectively.
The morphology of the NCM-exposed cells changed from day
1 onwards. By day 2, the exposed cells showed some dark
particles inside the cytoplasm. After addition of the differenti-
ation medium, the cell shape changed from spindle to round or
oval form, for 1–2 d, after which they exhibited secretory-like
cells morphology. The cell size increased gradually, while the
attachment properties of the induced cells decreased. From day
5 on, some of the exposed cells gained neural-like morphology
with long slender cell processes and small cell bodies.
Nestin assessment When the cells were exposed to NCM,
some dark particles were detectable under inverted micro-
scope from day 2 on (Fig. 3A, B). ICC staining demonstrated
nestin expression in the majority of the NCM-treated cells in
protocols I and IV (Fig. 3A, B), mouse brain as positive con-
trol (Fig. 3C), and no expression in untreated cells as negative
control (Fig. 3D) were used.
Morphology of IPCs In protocol I, the induced cells initially
passed through a nestin expression stage confirmed by ICC.
During the 3rd stage, in which the cells were cultured in high
glucose medium, the cell shape became round and oval (data
not shown). Three to four days later, the cells started to
Fig. 5 GAPDH (87 bp) and in-




aggregate. At stage 4, the cells aggregation proceeded and
resulted in islet-like structures (Fig. 4B).
In protocol II, after exposure of hUCMs to the induction
medium, the spindle shape cells became round, aggregated,
and formed islet-like cluster (Fig. 4C).
In protocol III, although the induced cells became round,
no obvious cluster was observed (Fig. 4D).
In protocol IV, induced hUCM cells formed small dark
particles in the cytoplasm after NCM treatment. During the
3rd stage, in which the cells were exposed to IPC-inducing
medium, the cell shape changed from spindle to a round
shape. During the following days of culture and induction,
cell size increased while the cell attachment decreased
(Fig. 4E). The cells in protocol IV formed more apparent
clusters than the other protocols (Fig. 4F).
Reverse transcriptase-PCR Gene expression was evaluated
by RT-PCR. GAPDH, as a reference gene was expressed sig-
nificantly in cultured cells. Insulin gene was expressed in the
induced cells collected from all four groups as well (Fig. 5).
Detect ion of insul in by immunocytochemistry
Immunocytochemical analysis was carried out on the induced
cells of either protocols. ICC revealed insulin (Fig. 6) and pro-
insulin (Fig. 7) protein production in all the protocols, but it was
higher in protocol IV compared with the other protocols.
Dithizone staining IPCs clusters in the different protocols
were stained with DTZ. The intensity and the extent of
DTZ-positive cells were more obvious in the new modified
protocol IV than the others (Fig. 8).
Fig. 6 Immunocytochemical analysis on insulin protein in the different protocols after pancreatic differentiation; the cell nuclei were counterstainedwith
Hoechst. Magnification ×200.
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Insulin, C peptide secretion, and glucose challenge test
The insulin and C peptide secretion rate in either protocols was
measured by using CLIA and EIA, respectively. The results
demonstrated that insulin secretion rate in the new modified pro-
tocol IV was significantly higher than the other groups (Table 3).
Discussion
In the preset study, we compared three commonly used induc-
tion protocols used for IPCs differentiation with a modified
protocol to achieve higher insulin production in vitro. Our
study demonstrated that exposure of human umbilical cord
matrix-derived mesenchymal cells to neuronal-conditioned
medium followed by 9 d induction with inducing agents
yields greater insulin and proinsulin intracellular protein pro-
duction which was confirmed by immunocytochemistry and a
sharper band of insulin gene in the modified protocol.
Considering DTZ staining results, the modified protocol IV
exhibited greater differentiation potential when the size of
clusters and dye intensity was considered among the groups.
DTZ is a zinc-binding substance (Shiroi et al. 2002), which is
used to visualize insulin granules of pancreatic β cells
(Chausmer 1998; Shiroi et al. 2002; Moshtagh et al. 2013).
Free ionized zinc serves as a reservoir for insulin granules in
the extra-granular space (Chausmer 1998). These zinc pools
are usually used to characterize IPCs (Shiroi et al. 2002;
Moshtagh et al. 2013). Increase in DTZ staining intensity in
protocol IV may indicate the higher number of differentiated
cells as well as increase in secretory granules.
Fig. 7 Immunocytochemical analysis on proinsulin protein in the different protocols after pancreatic differentiation; the cell nuclei were counterstained
with the Hoechst staining. Magnification ×200.
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Higher rate of insulin secretion in new modified protocol
paralleled the results obtained from ICC, DTZ, and RT-PCR.
It was the highest insulin secretion rate in protocol IV com-
pared with the other protocols. In addition when in vitro IPCs
were challenged with higher glucose concentrations, induced
cells in all the protocols responded by increase in insulin se-
cretion but the cultured cells in protocol IV secreted signifi-
cantly higher insulin amounts than the cells in the other
protocols.
Nestin, an intermediate filament predominantly expressed
in pancreas progenitor cells as well as neuron precursor cells,
is an important molecule for IPC differentiation (Hunziker and
Stein 2000; Zulewski et al. 2001). So we induced hUCM cells
to undergo an intermediate stage of nestin expression by in-
troduction of NCM at the initial stage of differentiation of
hUCMcells towards IPCs. Some similarities have been report-
ed between embryonic signaling pathways in IPCs and
neuroepithelial cells (Edlund 2001). Endoderm-derived pan-
creatic β cells and ectoderm-derived nerve cells are similar in
many features, including biosynthetic enzymes, transcription
factors, secretory, and metabolic proteins (Zulewski et al.
2001). Passage of stem cells through a nestin-positive stage
has been proposed as a necessary event for pancreatic differ-
entiation (Hori et al. 2005; Chao et al. 2008; Wei et al. 2013).
We first cultured hUCM cells in NCM containing-medium to
alleviate the nestin-positive cell population followed by incu-
bation of pretreated cells in IPC-inducing medium. The time
of exposure to NCM also plays an important role in IPC dif-
ferentiation. We examined three exposure times; 3, 5, and 7 d
and found that cultivation of hUCM cells for 3 d in NCM
results in a small number of nestin-positive cells, while exten-
sion of exposure time to 7 d, resulted in neuronal morphology
of the NCM-treated cells and a presecretory small number of
hUCMs. Considering these results, the most appropriate time
Fig. 8 Dithizone staning on
control and induced cells in
protocols I–IV. Magnification
×100. The diagram shows insulin
secretion in I–IV protocols. LG
low glucose medium, HG high
glucose medium.
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for the exposure of hUCMs to NCM was adjusted at 5 d,
during which more nestin-positive cells capable of differenti-
ating to IPCs were recognized. However, animal source of
NCM should be considered when it is to be used for human
regenerative procedures. Some sera (FBS, FCS) and compo-
nents (BSA) are among the mostly used materials which are
usually obtained from animals. Whether NCM can also be
used without the fear of xenogenic transformation needs to
be explored. Analysis of NCM components which may en-
hance differentiation of MSCs towards IPCs can reduce prob-
able xenogenic effects of NCM.
After the initial stage of nestin expression in the cultured
hUCM cells, they should undergo pancreatic induction by
endocrine- and pancreatic-inducing materials. The previous
studies have shown that several materials are critical or sup-
portive for pancreatic differentiation (Wong 2011). Some of
these inducing factors are: nicotinamide that promotes differ-
entiation of various stem cells into IPCSs and increase the
insulin and DNA content (Otonkoski et al. 1993; Gabr et al.
2008; Gao et al. 2008), exendin-4 that induces stem cell dif-
ferentiation (Gabr et al. 2008) and increase insulin secretion
from IPCs (Li et al. 2010), gastrin that stimulates islet differ-
entiation and islet growth (Wang et al. 1993), HGF that stim-
ulate the number of IPCs in cultured human islets (Otonkoski
et al. 1996), bFGF that promotes beta-cell differentiation and
may accelerate cluster formation (Hardikar et al. 2003),
activin A that increases insulin content and beta-cell differen-
tiation (Demeterco et al. 2000), betacellulin that plays some
role in cluster formation and induction of beta-cell differenti-
ation (Demeterco et al. 2000), and finally low concentration of
glucose that raises insulin content and high concentration that
increases beta-cell reproduction (Bonner-Weir et al. 1989).
The difference between new modified protocol IVand pro-
tocol II was the use of an initial stage of nestin preselection. An
initial exposure of hUCMs to NCM followed by prolonged
culture in the presence of inducing agents resulted in higher
rate of pancreatic differentiation and more insulin secretion.
Although nestin preselection is an important stage in the IPC
differentiation procedure, exposure of hUCMs to the extrinsic
materials has also a critical role. In protocol I, despite the nestin
preselection of hUCM cells, insulin secretion was lower than
protocol II that more components (Table 1) were used for IPC
differentiation. In contrast, in protocol II, the majority of the
inducing materials were used but the nestin preselection stage
was omitted. The insulin secretion following glucose challenge
test was higher than protocol I but lower than protocol IV. In
protocol III, only some of common inducing materials were
usedwithout nestin preselection stage, and the insulin secretion
was lower than the other protocols. As IPC differentiation is a
rather complicated phenomenon, an initial stage of nestin pre-
selection and appropriate inducingmaterials are both necessary
for adequate pancreatic differentiation.
Culture period is another important issue when the differen-
tiated stem cells are to be used in regenerative therapies. Shorter
protocols will reduce expenses, decrease the probability of con-
taminations that are mostly generated in the environmental con-
ditions, and increase the simplicity of the procedure. The new
modified protocol IV was 2 wk shorter than protocols I and III
but identical to protocol II. Nestin preselection stage of hUCM
cells followed by 9 d differentiation in an induction cocktail
promoted IPC differentiation and insulin secretion. However,
insulin secretion is still lower than in vivo environment. Change
in the inducing milieu such as 3D culture, co-culture of cells
with appropriate somatic cells, and other inducing components
may increase the efficacy of the models for IPC differentiation.
Conclusion
From the results, we may conclude that appropriate period of
nestin preselection stage followed by induction with adequate
inducing agents will enhance human umbilical cord matrix-
derived mesenchymal cells to differentiate into greater number
of insulin-producing cells and more insulin secretion in vitro.
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